Vieira De Sousa, E. C., Alves, P., Rodrigues, A. M., Teixeira, F., Tavares Costa, J., Bernardo, A., . . . Fonseca, J. E. (2020). GO-DACT: A phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis.
Chicago Style CitationVieira De Sousa, Elsa Cristina, et al. GO-DACT: A Phase 3b Randomised, Double-blind, Placebo-controlled Trial of GOlimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX in Improving DACTylitis in MTX-naive Patients With Psoriatic Arthritis. 2020.
MLA CitationVieira De Sousa, Elsa Cristina, et al. GO-DACT: A Phase 3b Randomised, Double-blind, Placebo-controlled Trial of GOlimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX in Improving DACTylitis in MTX-naive Patients With Psoriatic Arthritis. 2020.